Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 8—August 2007

Research

Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission

Anthony D. Harris*†Comments to Author , Jessina C. McGregor*, Judith A. Johnson*†, Sandra M. Strauss*, Anita C. Moore*, Harold C. Standiford‡, Joan N. Hebden‡, and J. Glenn Morris*
Author affiliations: *University of Maryland, Baltimore, Maryland, USA; †Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA; ‡University of Maryland Medical Center, Baltimore, Maryland, USA;

Main Article

Table 3

History of culture positivity with antimicrobial drug–resistant bacteria among 117 patients colonized with ESBL-producing bacteria at ICU admission*

Drug-resistant bacteriaNo. ESBL colonized (%)
ESBL-positive clinical cultures before ICU admission†6 (5)
ESBL-positive clinical cultures after colonization29 (25)
Methicillin-resistant Staphylococcus aureus25 (21)
Vancomycin-resistant enterococci‡27 (23)

*ESBL, extended-spectrum β-lactamase; ICU, intensive care unit.
†Positive clinical cultures during the same hospital admission but before ICU admission.
‡Clinical or surveillance cultures at any time before ICU admission.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO